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Purpose: To compare the results of 20, 23, 25 gauge pars plana vitrectomy (PPV) with two different gas
tamponades for idiopathic macular hole (MH) in a multi-surgeon vitroretinal practice.
Methods: In this comparative, retrospective, interventional case series, the medical charts of 142 eyes/130
patients were reviewed. Patients who matched our inclusion criteria: eye with stage 2, 3, or 4 MH that
underwent 20, 23, or 25 gauge PPV, internal limiting membrane (ILM) peeling, and fluid-gas exchange from
January, 2005 to May, 2012 and had at least 6 months follow-up. The best current corrected visual acuity (VA)
and anatomical status of the MH were assessed by optical coherent tomography (OCT) at 6 months, 1 year, and
2 years after vitrectomy.
Results: The MH closed successfully after primary vitrectomy in 86.5 % (20 gauge), 96.4 % (23 gauge), and 92 %
(25 gauge). Preoperative VA median were 20\126 (20 gauge), 20\100 (23 gauge), and 20\80 (25 gauge). At 6
months and 2 years postoperative VA did not differ significantly between the 3 groups (p = 0.570, and 0.054
respectively). However, at 12 months postoperative VA median 20\60 (20 gauge), 20\69 (23 gauge), and 20\40
(25 gauge) differ significantly (p = 0.005) likely due to cataract changes. The final median postoperative VA (at 2
years) in 25 gauge PPV group was 20/40 which was better than final visual outcomes for 20, and 23 gauge PPV
groups (20/50, and 20/55 respectively). The different was not a statistically significant. MH closed successfully in
96 % (C3F8), and 88.1 % (SF6) (p = 0.063). Preoperative median VA was 20/100 in both groups of gas. At 6 months,
1 year, and 2 years postoperative median VAs did not differ significant between the 2 groups (p = 0.076, 0.343,
and 0.309 respectively). MH closed successfully in (96.9 %) 12-14 % C3F8, and (95.3 %) 15-16 % C3F8 (p = 0.611).
MH closed in (82.1 %) 18-20 % SF6, and (96.4 %) 22-26 % SF6 (p=0.053).
Conclusion: Based on the results of this study, 20, 23, and 25 gauge of PPV have similar MH closure rates and VA
outcomes. SF6 at 22-26 % or C3F8 at 12-14 % achieved maximum closure rates.
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Idiopathic macular hole (MH) is relatively common cause
of visual loss, with women having about double the rate of
men. Although the pathophysiology of MH is not fully
known, it is strongly associated with certain factors such
as the presence of anteroposterior and tangential traction
[1]. Idiopathic full-thickness macular hole has an inci-
dence of approximately 1 per 1000 population causing
variable reduction of vision [2]. The natural course of MH
leads to a loss of central vision, which stabilizes between
20/200 and 20/400 [1]. Pars plana vitrectomy (PPV) with
intravitreal gas tamponade has been the established treat-
ment for MH since it was first described by Kelly and
Wendel in 1991. Surgery comprises a three-port PPV
combined with induction of a posterior hyaloid detach-
ment if not already present, removal of the posterior cor-
tical vitreous, and intraocular tamponade with long-acting
gas followed by a period of face-down positioning. PPV
relieves the antero-posterior and tangential traction re-
sponsible for induction and maintenance of the foveal de-
hiscence [3, 4]. Repair of MH was originally achieved by
performing 20-gauge PPV with removal of adherent cor-
tical vitreous, stripping of epiretinal membranes followed
by gas-fluid exchange, and prone positioning for at least
1 week [5]. Modifications in PPV instruments have led to
a decrease in gauge and consequently smaller incisions
[6]. A 25-gauge vitrectomy system with sutureless self-
sealing sclerotomies was first introduced and found it to
be safe surgical procedure in a variety of viteoretinal path-
ologies [6, 7]. In 2005, Eckardt promoted the 23-gauge
transconjunctival system, targeted at combining the bene-
fits of 25- and 20-gauge instrumentation, as a way to over-
come some of disadvantages of 25-gauge system at the
time [8]. Because of its well-known intraoperative and post-
operative advantage, that is, reduction of surgical time and
postoperative inflammation, and less pain, small-gauge
transconjunctival vitrectomy is gaining wide acceptance [7].
Modifications have been proposed to increase the rate of
closure, such as the use of:- different gases (sulfur hexa-
fluoride [SF6]; hexafluoroethane [C2F6]; octoflouropropane
[C3F8]) and variation in the post-operative time for face-
down positioning. Other advances have been internal limit-
ing membrane (ILM) peeling with or without dye to further
relieve traction on the hole [9], and the use of adjuncts such
as autologous serum and fibrin, transforming growth factor
beta, platelets, and thrombin to aid in the wound healing
process [2]. Despite of all these developments, there has
been little research comparing functional and anatomical
efficacy of three gauge PPV systems when used for treating
MH. The purpose of this study is to evaluate the anatom-
ical and functional outcomes of these systems for MH man-
agement when employ by a multi-surgeon practice, Illinois
Retina Associates. All members of this practice are on fac-
ulty in Department of Ophthalmology at Rush UniversityMedical Center. The findings can help to optimize surgical
outcomes by comparing success rate and complications for
20, 23, and 25 gauge PPV using various concentrations of
sulfur hexafluoride (SF6) or perfluoropropane (C3F8).
Methods
Study design
This study was a comparative, retrospective, interventional
case series. The medical charts of 142 eyes of 131 patients
were reviewed. This study was approved by the Rush Uni-
versity Medical Center institutional review board. All eyes
that underwent PPV for MH from January, 2005 to May,
2012 and had at least 6 months of follow-up were included.
Inclusion criteria included all eyes with stage 2, 3, or 4 MH
(Gass classification) [10] and [11] that underwent 20, 23, or
25 gauge PPV, ILM peeling, and fluid-gas exchange. Exclu-
sion criteria included myopia higher than 8D, epiretinal
membrane, previous retinal diseases, traumatic MH, and
any past history of vitreoretinal surgery. The best current
correction of visual acuity (VA) and anatomical status of
the MH as assessed by optical coherent tomography (OCT)
were examined at the preoperative visit, 6 months, 1 year
and 2 years after PPV. All eyes underwent complete pre-
operative and postoperative slit-lamp biomicro-scopy
examination, VA, and dilated fundus examination.
Data collected included age, sex, gender, MH stage,
ethnicity, preoperative VA, preoperative lens status, ret-
inal status, postoperative lens status, retinal status of
other eye, MH status, VAs at 6 months, 1 year, and
2 years, and any intra or postoperative complications.
The surgical procedure was as follows
Surgery was performed under local or general anesthesia.
All patients underwent PPV with 20, 23, or 25 gauge,
standard 3-port approach. View of the posterior segment
was achieved with binocular wide-field viewing system or
contact lens. A core vitrectomy was performed. Posterior
vitreous separation was created (in stage 2 and 3 MH)
using the vitreous cutter on aspiration only. The posterior
hyaloid was peeled, and the vitreous gel trimmed to the
periphery. Indocyanine green (ICG) dye was then infused
into eye (in 137 eyes/ 96.5 %) to stain vitreous and ILM. A
pick, Tano scraper and/ or microforceps were used to peel
the ILM around the MH in all cases. Peripheral retinal
examination via microscope or indirect ophthalmoscopy
was performed. Indirect or endolaser photocoagulation
was applied to any peripheral retinal tears or suspicious
retinal lesions (e.g., lattice degeneration, retinal tuft, and
peripheral retinal breaks). Fluid-gas exchange was per-
formed in all cases and 12 %-16 % C3F8 or 18 %-26 % SF6
was used as tamponade. Subconjunctival antibiotic and
dexamethasone were generally given.
Patients were advised to maintain maximal face down
positioning for 1-2 weeks postoperatively. No adjuvants
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nisolone acetate, and atropine eye drops were given to all
patients as standard care at our institution.
During postoperative evaluations, patients were examined
at 1 day, 1 week, 1 month, 6 months, 1 year, and 2 years.
Measurement of VAs was recorded. The anatomical closure
was determined after surgery by using indirect slit lamp
biomicro-scopy and OCT imaging. Any complications were
documented.
Primary outcome variables were postoperative VAs at
6 months, 1 year, and 2 years, which was recorded as a
Snellen visual acuity and converted to logarithm of minimal
angle of resolution units (LogMAR) for statistical analysis.
Secondary outcome measure in this study was anatomical
closure rate. Comparing these 2 outcomes between 3
groups of vitrectomy (20 vs 23 vs 25 gauge vitrectomy) and
between 2 gas groups (C3F8 group vs SF6 group).
Statistical analysis
SPSS version 18.0 was used for statistical analysis. De-
scriptive analysis was performed on all variables and their
distribution assessed. A Chi-square test was used to com-
pare categorical variables among the groups and Fisher
exact test was used when the sample size was small. A
non-parametric analysis was selected to compare VA me-
dians among the groups. The difference between the
groups was assessed for statistical significance using
Kruskal-Wallis test, Mann-Whitney U test as pair wise
difference among the groups, and Wilcoxon test was used
to estimate differences before and after treatment. The
general linear model/ Analysis of Covariance were used to
control any confounders. We hypothesized that there
would no statistical significant difference in our primary
outcome of VAs or secondary outcome of MH closure at
2 years, between 20, 23, and 25 gauge PPV, and between
SF6 and C3F8 groups. A P value ≤ 0.050 was considered
significant for all tests.
Results
Patients demographics and baseline characteristics
Total of one hundred forty two eyes of 130 patients were
studied. The mean follow-up duration ± standard devi-
ation (SD) was 27.8 ± 15.2 months (rang, 6-72 month).
Most of the patients were Caucasian 73.9 %, others were
African-American 16 %, Hispanic 7 %, and Asiatic 2.1 %.
ICG dye used during surgery in 137 eyes (96.5 %),
Methyline blue in 1 eye (0.7 %), no dye used in 2 eyes
(1.4 %), and Triesence used in 2 eyes (1.4 %).
There were 37 eyes in 20 gauge group, 55 eyes in 23
gauge group, and 50 eyes in 25 gauge group. The 3 groups
had similar baseline characteristic in terms of age, gender,
stage of MH, preoperative VAs, and preoperative lens status
(Table 1). Preoperative VA medians were 0.80 (20/126),
range 0.30-2.30 (20/40-count fingers at 1 feet) in 20 gaugegroup, 0.70 (20/100), range 0.18-1.82 (20/30-count fingers
at 3 feet) in 23 gauge group, and 0.60 (20/80), range 0.40-
1.70 (20/50- count fingers at 4 feet) in 25 gauge group. A
total of 31 patients achieved 2 years of follow-up (83.7 %)
in 20 gauge group, 30 patients achieved 2 years of follow-
up (54.5 %) in 23 gauge group, and 34 patients achieved
2 years of follow-up (68 %) in 25 gauge group.
Visual and anatomical outcomes
In the 20 gauge group, the medians postoperative VAs
were 20/110; range, 20/20 to count finger at 2 feet (p =
0.883) at 6 months, 20/60; range, 20/20 to count finger at
2 feet (p = 0.004) at 1 year, and 20/50; range, 20/20 to
count finger at 2 feet (p = 0.001) at 2 years. In the 23 gauge
group, the medians postoperative VAs were 20/80; range,
20/25 to count finger at 2 feet (p = 0.026) at 6 months,
20/69; range, 20/25 to count finger at 6 feet (p = 0.018) at
1 year, and 20/55; range, 20/20 to count finger at 5 feet (p =
0.001) at 2 years. In 25 gauge group, the medians postopera-
tive VAs were 20/76; range, 20/20 to count finger at 2 feet
(p = 0.192) at 6 months, 20/40; range, 20/20 to count finger
at 5 feet (p < 0.001) at 1 year, and 20/40; range, 20/20 to
count finger at 5 feet (p < 0.001) at 2 years. In the 3 groups
the VA improved significantly at 1, and 2 years after PPV
compared to preoperative VA.
One year postoperative VA (median) was significantly
better than 6 months postoperative VA (median) in 20
gauge PPV, and 25 gauge PPV group but in 23 gauge the
VA improvement was not statistically different (Table 2).
Two years postoperative VA (median) was significantly
better than 1 year postoperative VA (median) in 23 gauge.
However, in 20, and 25 gauge PPV groups the VA im-
provement was not statistical different (Table 2).
Comparison between the 3 groups at 6 months and
2 years, the median VAs did not differ statistically
between the 3 groups 20/110, 20/80, and 20/76 at
6 months and 20/50, 20/55, and 20/40 at 2 years, p =
0.570, and p = 0.054 respectively. At 1 year, the median
postoperative VAs were statistically different between
20, 23, 25 gauge groups, 20/60, 20/69, 20/40 respectively
with p = 0.005. Follow-up tests were conducted to evalu-
ate pairwise differences the 3 groups (comparing 20, 23
gauge group, 20, 25 gauge group, and 23, 25 gauge
group), controlling for type I error across the tests
among the groups by using Bonferroni approach. The
results showed there was no statistically difference be-
tween 20 gauge group and 23 gauge group (p = 0.145),
and between 20 gauge group and 25 gauge group (p =
0.073). However, the results showed there was statisti-
cally significant difference between 23 gauge group and
25 gauge group (p = 0.002) (Fig 1).
General linear model/ Analysis of Covariance conducted
for factors that would be expected to bias the visual acuity
difference between the 3 groups of vitrectomy at 1 year.
Table 1 Baseline patients demographics for different gauge groups
Parameter All eyes, n=142 20 Gauge, n=37 23 Gauge, n=55 25 Gauge, n=50 P value
Age, years
Mean ±SD 67.8±8.5 69±8.6 67±8.3 66.8±8.5 0.263a
Range 46-87 47-87 47-86 46-86
Gender, n, %
Female 98 (69 %) 27 (73 %) 38 (69.1 %) 33 (66 %) 0.785b
Male 44 (31 %) 10 (27 %) 17 (30.9 %) 17 (34 %)
Preoperative VA
Median (logMAR) 0.70 0.80 0.70 0.60 0.237c
0.18-2.30 0.30-2.30 0.18-1.82 0.40-1.70
Range (logMAR)
Lens Status, n, % 116 (81.7 %) 27 (73 %) 48 (87.3 %) 41 (82 %) 0.229b
Phakic 26 (18.3 %) 10 (27 %) 7 (12.7 %) 9 (18 %)
Pseudophakic
Stage of MH, n, % 47 (33.1 %) 9 (24.3 %) 22 (40 %) 16 (32 %)
Stage 2 54 (38 %) 18 (48.6 %) 19 (34.5 %) 17 (34 %) 0.226b
Stage 3 36 (25.4 %) 8 (21.6 %) 11 (20 %) 17 (34 %)
Stage 4
ICG 137 (96.5 %) 52 (94.5 %) 52 (94.5 %) 49 (98 %) 0.760b
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(p = 0.136) when the post-operative 1 year lens status was
adjusted. Cataract changes were recorded at 1 year after
surgery as the following 9 patients (25.7 %) in 20 gauge
group, 21 patients (43.8 %) in 23 gauge group, and 11 pa-
tients (23.4 %) in 25 gauge group with P = 0.070. At
2 years, 27 patients (84.4 %) were pseudophakic in 20
gauge group, 27 patients (79.4 %) were pseudophakic in
23 gauge group, and 37 patients (94.9 %) in 25 gauge
group with P = 0.138 (Fig. 2).
Successful primary anatomical closure of MH was
achieved in majority of eyes in each of the 3 groups. The
MH was closed in 32 of 37 eyes (86.5 %) underwent 20
gauge PPV, 53 of 55 eyes (96.4 %) underwent 23 gauge
PPV, and 46 of 50 eyes (92 %) underwent 25 gauge PPV.
The difference in MH closure between the 3 groups was
not statistically significant (p = 0.220) (Fig. 3).
For the eyes in which MH was closed successfully, VA
was 20/63 or better in 63.6 % of 20 gauge PPV group,
55.5 % in 23 gauge PPV group, and 79.4 % in 25 gaugeTable 2 Comparison in VA improvement postoperative 6 months an
Gauge VA at 6 months VA at 1 year P v
20 gauge 20/110 20/60 0.0
23 gauge 20/80 20/69 0.8
25 gauge 20/76 20/40 0.0PPV group at 2 years follow-up visit (Table 3). 10.2 % of
all eyes which MH closed achieved vision of 20/20, and
71.4 % achieved visual acuity better than 20/64.
Results of gas groups
Seventy five eyes underwent PPV with injection of 12-
16 % C3F8 gas tamponade and 67 eyes underwent PPV
with 18-26 % SF6. Baseline demographic variables were
compared for any statistical difference including duration
of face down positioning in both groups (Table 4).
Functional and anatomical outcomes for gases
Visual acuity in C3F8 versus SF6
The median preoperative VA for eyes treated with C3F8
was 0.70 (20/100), range 0.30 – 2.30 (20/40 to count finger
at 1 feet). In eyes treated with SF6 preoperative median
was 0.70 (20/100), range 0.18- 1.82 (20/30 to count finger
at 3 feet). At 6 months, 1 year, and 2 years, the medians
postoperative VA were 20/100, 20/69, and 20/50 in C3F8
group and 20/69, 20/50, and 20/40 in SF6 group. Thed 1 year, and 1 year and 2 years in each gauge
alue VA at 1 year VA at 2 years P value
11 20/60 20/50 0.188
64 20/69 20/55 0.003
02 20/ 40 20/40 0.268
Fig. 1 Graph showing preoperative and postoperative logarithm of
minimal angle of resolution (logMAR) visual acuity (median) in 20, 23,
or 25 gauge vitrectomy systems
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nificant (p = 0.076 at 6 months, p = 0.343 at 1 year, and
p = 0.309 at 2 years).
Anatomical outcome of C3F8 versus SF6
The MH was successfully closed after single surgery with
higher rate in long-acting tamponade C3F8 group com-
paring with short-acting tamponade SF6 group. The MH
closed in 72 eyes (96 %) in C3F8 group, and in 59 eyes
(88.1 %) in SF6 group, the difference was not statistically
significant (p = 0.073) (Fig. 4). Adjusting for age, pre-
operative VA, stage of MH, duration of face down posi-
tioning, and vitrectomy, the difference in success rate
between gases remained not significant (P = 0.063).
Subgroup analysis conducted to compare different con-
centration of each gas. MH closure was achieved in 31 of
32 eyes (96.9 %) treated with 12-14 % C3F8 compared with
MH closed in 41 of 43 eyes (95.3 %) treated with 15-16 %
C3F8 with (p = 0.611). MH closure rate was comparedFig. 2 Graph showing Lens Status at 1 and 2 years postoperatively in eyesbetween eyes which treated with 18-20 % SF6 and eyes
treated with 22-26 % SF6. The MH closed in 32 of 39 eyes
(82.1 %), and 27 of 28 eyes (96.4 %) respectively with (p =
0.073), although 22-26 % SF6 group had more stage 4 MH
than 18-20 % SF6 group it achieved higher closure rate. Lo-
gistic regression conducted for the 2 groups of SF6 gas con-
trolling for vitrectomy, MH stage, preoperative VA, and
duration of face down postioning. The results showed the
gas was only marginally significant (p = 0.053). Comparison
between the four groups of gases (12-14 % C3F8 vs 15-
16 % C3F8 vs 18-20 % SF6 vs 22-26 % SF6). The difference
was significant between the 4 groups with p = 0.048 (Fig. 5).
Complications
Cataract progression or formation was recorded 67.6 %
in 20 gauge group, 70.9 % in 23 gauge group, and 64 %
in 25 gauge group. 4 eyes (2.8 %) developed retinal de-
tachment post MH repair. The distribution was in 5.4 %
(2 eyes) in the 20 gauge, 1.8 % (1 eye) in the 23 gauge,
and 2 % (1 eye) in the 25 gauge. No choroidal detach-
ment, vitreous hemorrhage, or endophthalmitis was re-
corded in any group.
Re-operations
Eleven eyes did not close after primary vitrectomy, 8
eyes closed successfully after secondary vitrectomy with
fluid-gas exchange, 2 eyes closed after secondary vitrec-
tomy with Silicon oil tamponade, and only one eye suf-
fered closure failure (chronic MH).
Discussion
Since the original description of MH repair, macular hole
surgery has been reported to have increasing success rates,
now around 90 % [12]. This study reported MH closure
rates of 92.3 % with the ILM peeling, fluid-gas exchange
with C3F8 or SF6, and face down positioning matchingtreated with 20, 23, or 25 gauge PPV systems
Fig. 3 Graph showing Macular hole status in different types of PPV systems after single surgery
Table 4 Baseline patients demographics for different gas groups
Parameter C3F8, n= 75 SF6, n= 67 P value
Age, years
Mean ±SD 69.8±8.3 65.6±8.2 0.003a
Range 47-87 46-86
Gender, n, %
Female 49/ 65.3 % 49/73.1 % 0.316c
Male 26/34.7 % 18/26.9 %
Preoperative VA
Median (logMAR) 0.70 0.70 0.381b
Range (logMAR) 0.30-2.30 0.18-1.82
Lens Status, n, %
Phakic 54/75 % 62/92.5 % 0.002c
Pseudophakic 12/28 % 5/7.5 %
Stage of MH, n, %
Stage 2 24/32 % 23/34 %
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al [14]. Primary anatomical closure rate for MH in 23
(96.4 %) and in 25 (92 %) gauge PPV were similar to those
reported by Kusuhara et al [15]. For 20 gauge PPV group,
the MH closure rates (86.5 %) was higher than what
Goncu et al [8] reported but lower than what Krishnan et
al [3] reported. However, comparing MH closure rate be-
tween the 3 groups was not statistically significant. This
has been reported in other studies but as pair-wise com-
parison [3, 7, 8, 15]. The results of the present study
showed that 20, 23, and 25 gauge PPV would be equally
effective techniques for MH management. The final visual
acuity increased significantly in the 3 groups in this study.
In 20, and 25 gauge PPV group VAs improved at 6 months
compared with preoperative but not statistically signifi-
cantly. At 1 year and 2 years, both groups showed statisti-
cally significant improvement in VAs compared with
preoperative VAs. On the other hand, in the 23 gauge
PPV group VA improved statistically significantly at
6 months, 1 year, and 2 years compared with the pre-
operative VAs. At one year, postoperative VA (median)
was significantly better than 6 months postoperative VA
(median) in 20 gauge PPV, and 25 gauge PPV groups.
However, in 23 gauge group, the VA improvement was
not statistically different. This discrepancy in the results is
due to cataract progression or formation.
Analysis of the present study showed that the percent-
age of patients who underwent cataract extraction in theTable 3 Final VA ranges for different PPV systems in patients
who completed 2 years follow-up
VA 20 Gauge 23 Gauge 25 Gauge
20/40 or better 35.7 % 44.1 % 72.2 %
20/41 to 20/63 32.1 % 14.7 % 13.8 %
20/64 to 20/80 10.7 % 14.7 % 5.5 %
Worse than 20/80 21.4 % 26.4 % 8.3 %first year post PPV was higher in the 20 and 25 gauge
PPV groups than in the 23 gauge group. The percentage
of the patients who were pseudophakic at 1 year was
74.3 % in 20 gauge group, 56.8 % in 23 gauge group, and
76.6 % in 25 gauge group. At 2 years, postoperative VA
(median) was significantly better than 1 year postopera-
tive VA (median) in 23 gauge. However, in 20, and 25
gauge PPV groups the VA improvement was not statis-
tical difference compared with postoperative 1 year VAs,Stage 3 34/46 % 20/30 % 0.022c
Stage 4 12/16 % 24/36 %
ICG 75/100 % 62/92.5 % 0.055c
Duration face-down
positioning, Mean by Day 9.1 8.5 0.126a
Abbreviation: n number, % percent
aT-test
bMann-Whitney U test
cChi-square test and Fisher’s exact test
Fig. 4 Graph showing macular hole closure rate and type of intraocular tamponade. The overall percentage of eyes with successful MH closure
was higher in the eyes treated with Perfluoropropane (C3F8) compared with eyes treated with Sulfur hexafluoride (SF6)
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cataract extraction in the second year post MH repair.
Comparing the 3 groups at six months, 1 year, or 2 years
postoperatively, final median VAs did not different sig-
nificantly between the groups (p = 0.570, p = 0.136, and
p = 0.054, respectively) matched other study results
(pair-wise comparison these studies follow-up period
variables from 6 months to 2 years) [3, 7, 8, 15]. The
final visual outcomes for the 20, 23, and 25 gauge PPV
groups in this study were similar in the 3 groups (20/50,
20/55, and 20/40 respectively) which were better than
what Kishnan et al [3], and Goncu et al [8] have found
for 20 and 23 gauge PPV. The better result in current
study could be due to better baseline (preoperative) vis-
ual acuities compared with the previous two studies,Fig. 5 Graph showing macular hole closure and type of intraocular tampona
successful MH closure was higher in the eyes treated with Perfluoropropane (
with eyes treated with Sulfur hexafluoride (SF6) at 18-20 %although this study included patients without any limita-
tions for duration of the macular hole in comparison
with the previous two studies. The 20 gauge PPV group
in this study achieved final median postoperative VA
which is consistent with Gupta et al results for 132 cases
underwent 20 gauge PPV with phacoemulsification and
intraocular lens implantation [16]. Moreover, the 23 gauge
PPV group in this study had final visual outcome similar
to the visual outcome reported by Sanisoglu et al [17] in
50 cases of 23 gauge PPV whose a baseline preoperative
VA was similar to our group. Furthermore, 25 gauge PPV
group achieved better final visual outcome compared with
what Carvounis et al reported [5] although the 25 gauge
PPV group in our study had similar preoperative VA to
Carvounis et al study. Finally, in cases of macular holesde with different concentrations of gas. The percentage of eyes with
C3F8) 12-14 %, 15-16 %, and 22-26 % Sulfur hexafluoride (SF6) compared
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dian best corrected visual acuity of 20/67 in 77 cases with
follow-up range 2 to 24 months [13] which is less than
what we report.
Gas tamponade plays an important role in hole closure
during macular hole surgery, as the gas provides a scaffold
for glial proliferation, and its surface tension may exclude
vitreous fluid from the subretinal space [18]. ILM peeling
is widely considered to facilitate macular hole closure, per-
haps by removing an element of traction or by stimulating
gliosis [14]. To maximize the effects of the gas, a long-
acting gas and a long duration of face-down positioning
have both been used [18], although a majority of vitreoret-
inal surgeons use C3F8, approximately one-third report
using SF6 with excellent results [14, 18].
In this study, the MH closure rate was higher in eyes
treated with 12-16 % C3F8 (96 %) than eyes treated with
18-26 % SF6 (88.1 %), however the difference was not sta-
tistically significant. Using long-acting gas or short-acting
gas as tamponade in MH repair is still controversial, as it
has been reported that long-acting gas has better closure
rates Thompson et al documented [19], while Kim et al
reported that there was similar MH closure rate between
16 % C3F8 and 20 % SF6 (91 % versus 90 %) [14]. It is dif-
ficult to compare the results of our study with results of
previously reported studies, because of a difference in gas
concentrations for the two gases, and also due to the in-
clusion of a large number of stage 4 MHs especially in the
SF6 group. For example Xirou et al [18] used one concen-
tration of each gas, 14 % C3F8 and 20 % SF6, but no stage
4 where included in SF6 group.
Subgroup analysis for C3F8 group showed MH treated
with 12-14 % C3F8 achieved closure rate of 96.9 %, and eyes
treated with 15-16 % C3F8 achieved closure rate of 95.3 %.
No statistical significant difference was found. This is con-
sistent with the results reported by some previous studies
[13, 19, 20] and better than [21]. For SF6 group, eyes treated
with 18-20 % SF6, MH closed in 83.1 % which was lower
compared with eyes treated with 22-26 % SF6 (96.4 %) des-
pite the fact that stage 4 MHs was higher in the second
group compared to the first one (39.3 % versus 33.3 %).
Postoperative median VA improved significantly at
6 months in the SF6 group comparing with preopera-
tively. The C3F8 group did not improve and stayed the
same at 20/100. However, the postoperative median VAs
at 1 year and 2 years improved in the 2 groups. Our re-
sults are similar to previously published studies [14, 18].
Advantages of SF6 include earlier confirmation of clos-
ure compared with the C3F8 group and sooner return to
air travel and normal daily activities because of more
rapid visual recovery commensurate with gas resorption.
Closure of macular holes within 3 days after ILM peeling
has been reported with confirmation by optical coher-
ence tomography imaging [14]. According to our study,using short-acting 22-26 % SF6 tamponde for MH sur-
gery would be good choice for patients who need rapid
visual acuity rehabilitation as it had achieved a similar
closure rate to long-acting C3F8 gas tamponade.
Cataract progression or formation is most common com-
plication after MH surgery primarily due to the removal of
vitreous and the prolonged exposure to gas [13]. In our
study, cataract progression or formation was similar in the
3 groups as most of patients required cataract extraction
during the follow-up period. However, in the 25 gauge
group, the number of pseudophakic eyes was more than in
the other 2 groups. This difference could possibly have be
related to the gauge system itself as the 25 gauge system
might have allowed more complete removal of vitreous gel
around the crystalline lens promoting faster cataract forma-
tion compared with the 20 and 23 gauge systems.
There have been several reports about the association be-
tween bilateral MH and risk of MH reopening after suc-
cessful PPV. In our study, 11 bilateral MHs were studied
without any reopening of previous closed MH consistent
with Passemard et al publication [22]. In this study, we
recorded 4 cases of post PPV retinal detachement (2.8 %)
which was lower than previous studies that reported RD
occurrence at rates from 3-14 % [22]. No postoperative
cases of endophthalmitis occurred in our study. Limitation
of this study are retrospective nature, small sample size es-
pecially for the 20 gauge PPV group, missed data (over all
we had 23 % of patients data missed at 2 years, in 20 gauge
group it was 16.2 %, in 23 gauge group it was 45.4 %, and
in 25 gauge group it was 32 %), and a multi-surgeon data
set. The varying proficiency of the surgeons could affect the
study outcome. However, our results provide useful data
that could aid in planning of further prospective, random-
ized clinical studies.Conclusion
In conclusion, based on the results of this study, 20, 23, and
25 gauge of PPV have similar macular hole closure rates
and VA outcomes. SF6 at 22-26 % or C3F6 at 12-14 %
achieved maximum closure rates.
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